Pharmaceuticals
-
Novel test for complications of pneumonia
A new test has been developed to identify pneumonia patients who may be at risk of respiratory failure or sepsis, it was announced today. Read more
-
Oral steroid warning for asthma patients
Too many people with severe asthma are at risk through the use of oral steroids, a major European conference will hear today. Read more
-
Backing for asthma triple therapy inhaler
A triple therapy inhaler may be the best way to help patients with severe and uncontrolled asthma, according to the findings of a major international study. Read more
-
Placebos may not be placebo – analysis
Clinical researchers should give more information about placebos – as sometimes they may be more active than described, according to an analysis published today. Read more
-
Cancer drug benefits exaggerated – claim
The benefits of new cancer drugs continue to be exaggerated in reporting of key trials, it was alleged today. Read more
-
Method of breath-holding for radiotherapy success
Researchers say they are perfecting a breath-holding technique that will allow cancer patients to stay completely still during extended radiotherapy sessions. Read more
-
Cancer therapy response ‘eNose’ test
Researchers have created an ‘electronic nose’ that can effectively predict individual patient responses to immunotherapy, it was announced today. Read more
-
Puberty and menopause link to type 2 diabetes risk
Having a longer menstrual cycle and using the contraceptive pill are linked to an increased risk of developing type 2 diabetes, French researchers claim today (17 September 2019). Read more
-
Hope for proton therapy after drug breakthrough
Cancer patients needing proton therapy could benefit from more effective treatment after scientists in Norway discovered that light-activated drugs transform the treatment. Read more
-
Statins benefit peripheral arterial disease
Adhering to statin treatment can reduce the risk of death among patients with peripheral arterial disease, Swiss researchers have reported. Read more
